Arrowhead Pharmaceuticals Inc (ARWR)
Profitability ratios
Return on sales
| Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | |
|---|---|---|---|---|---|
| Gross profit margin | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating profit margin | 11.86% | -16,927.06% | -85.16% | -73.39% | -107.77% |
| Pretax margin | 2.39% | -17,247.54% | -85.78% | -71.01% | -101.85% |
| Net profit margin | -0.20% | -16,882.37% | -85.27% | -72.56% | -101.85% |
Return on investment
| Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 7.10% | -52.74% | -26.78% | -25.80% | -20.99% |
| Return on assets (ROA) | -0.12% | -52.60% | -26.81% | -25.51% | -19.83% |
| Return on total capital | 0.00% | -312.82% | -69.35% | -44.79% | -34.45% |
| Return on equity (ROE) | -0.35% | -323.27% | -75.65% | -44.29% | -34.45% |